In a report released yesterday, Matt Bottomley from Canaccord Genuity maintained a Hold rating on HEXO (HEXO), with a price target of C$7.00. The company’s shares closed last Monday at $6.18.
According to TipRanks.com, Bottomley is a 5-star analyst with an average return of 29.0% and a 54.3% success rate. Bottomley covers the Basic Materials sector, focusing on stocks such as Harvest Health & Recreation, Goodness Growth Holdings, and Green Thumb Industries.
Currently, the analyst consensus on HEXO is a Hold with an average price target of $7.84, implying a 28.7% upside from current levels. In a report released yesterday, MKM Partners also maintained a Hold rating on the stock with a C$8.00 price target.
See today’s analyst top recommended stocks >>
Based on HEXO’s latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of $32.88 million and GAAP net loss of $20.84 million. In comparison, last year the company earned revenue of $17.01 million and had a GAAP net loss of $298 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HEXO Corp. engages in the manufacture, production, and distribution of medicinal marijuana. It offers products through the Time of Day, H2, Decarb, and Exlixir No. 1 brands. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.
Read More on HEXO:
